Food and Drug Administration (FDA) for weekly use for weight management in obese (BMI 30 or more) and overweight (BMI 27 or more) individuals, and treatment of type 2 diabetes, respectively
GPX:Glutathione Peroxidase
Nausea, diarrhea, decreased appetite, vomiting, and constipation occur in a dose-dependent manner, with higher rates at maximum doses, and typically diminish in severity as treatment continues
Available as a weekly injection or a daily oral pill, semaglutide works by acting like the hormone GLP-1, reducing appetite and promoting sustained weight loss
Why Compounded GLP-1 Changes the Cost Equation The GLP-1 vs gastric sleeve cost comparison shifts dramatically with compounded medication
If no reaction occurs, the product may be safe to use